Wang H, Jiao Y, Ma Q, Liu YH. Overview of endoscopic biliary stenting in malignant obstructive jaundice. World J Gastrointest Surg 2025; 17(2): 103378 [DOI: 10.4240/wjgs.v17.i2.103378]
Corresponding Author of This Article
Ya-Hui Liu, MD, PhD, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun 130021, Jilin Province, China. yahui@jlu.edu.cn
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Feb 27, 2025; 17(2): 103378 Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.103378
Overview of endoscopic biliary stenting in malignant obstructive jaundice
Hui Wang, Yan Jiao, Qiang Ma, Ya-Hui Liu
Hui Wang, First Operation Room, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China
Yan Jiao, Ya-Hui Liu, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China
Qiang Ma, Department of Emergency Surgery, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China
Co-corresponding authors: Qiang Ma and Ya-Hui Liu.
Author contributions: Liu YH designed the overall concept and outline of the manuscript; Wang H and Ma Q contributed to the discussion and design of the manuscript; Jiao Y and Wang H wrote and edited the manuscript, illustrations, and reviewed the literature; Ma Q and Liu YH contributed equally as co-corresponding authors.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ya-Hui Liu, MD, PhD, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun 130021, Jilin Province, China. yahui@jlu.edu.cn
Received: November 19, 2024 Revised: December 19, 2024 Accepted: December 31, 2024 Published online: February 27, 2025 Processing time: 65 Days and 2 Hours
Abstract
This article discusses Wang et al’s essay. Endoscopic biliary stenting, a less invasive alternative to surgery, is effective for malignant obstructive jaundice. This article summarizes the pathophysiology of biliary obstruction, the technical aspects of stenting, and the clinical outcomes. By comparison of endoscopic stenting with percutaneous biliary drainage, improvements and complications are focused on. Additionally, patient selection for stenting and future advancements in stent technology are important. Overall, endoscopic biliary stenting is a valuable palliative option for patients with malignant jaundice, especially those ineligibles for surgery.
Core Tip: Endoscopic biliary stenting is a vital palliative procedure for managing malignant obstructive jaundice, particularly in cases of distal obstruction. The procedure’s success relies on careful patient selection, accounting for factors such as tumor location, stent type, and potential complications. Recent innovations, including drug-eluting and 3-dimensional-printed stents, have enhanced clinical outcomes. A multidisciplinary approach ensures individualized treatment planning, better complication management, and improved overall patient care.
